US7632955B2
(en)
|
2001-12-13 |
2009-12-15 |
National Health Research Institutes |
Indole compounds
|
US7528165B2
(en)
|
2001-12-13 |
2009-05-05 |
National Health Research Institutes |
Indole compounds
|
ES2527118T3
(es)
|
2003-12-19 |
2015-01-20 |
Plexxikon Inc. |
Compuestos y procedimientos de desarrollo de moduladores de Ret
|
EP1730146B1
(en)
*
|
2004-03-30 |
2011-05-04 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of jak and other protein kinases
|
US7498342B2
(en)
*
|
2004-06-17 |
2009-03-03 |
Plexxikon, Inc. |
Compounds modulating c-kit activity
|
US7709645B2
(en)
*
|
2004-07-27 |
2010-05-04 |
Sgx Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
US7626021B2
(en)
*
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
EP2239262A3
(en)
|
2004-07-27 |
2011-10-19 |
SGX Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
US7361764B2
(en)
|
2004-07-27 |
2008-04-22 |
Sgx Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
EP1781654A1
(en)
|
2004-07-27 |
2007-05-09 |
SGX Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
WO2006063167A1
(en)
*
|
2004-12-08 |
2006-06-15 |
Smithkline Beecham Corporation |
1h-pyrrolo[2,3-b]pyridines
|
US7456289B2
(en)
*
|
2004-12-31 |
2008-11-25 |
National Health Research Institutes |
Anti-tumor compounds
|
WO2006109085A1
(en)
|
2005-04-13 |
2006-10-19 |
Astex Therapeutics Limited |
Hydroxybenzamide derivatives and their use as inhibitors of hsp90
|
BRPI0610066A2
(pt)
*
|
2005-05-17 |
2010-05-25 |
Plexxikon Inc |
compostos que modulam atividade de c-kit e c-fms e usos para estes
|
CN102603581B
(zh)
|
2005-06-22 |
2015-06-24 |
普莱希科公司 |
作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
CA2636189A1
(en)
|
2006-01-17 |
2007-07-26 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of janus kinases
|
US7754725B2
(en)
|
2006-03-01 |
2010-07-13 |
Astex Therapeutics Ltd. |
Dihydroxyphenyl isoindolymethanones
|
DE102006012617A1
(de)
*
|
2006-03-20 |
2007-09-27 |
Merck Patent Gmbh |
4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
AU2007254179B2
(en)
*
|
2006-05-18 |
2013-03-21 |
Pharmacyclics Llc |
Intracellular kinase inhibitors
|
US20070286864A1
(en)
*
|
2006-06-09 |
2007-12-13 |
Buck Elizabeth A |
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
PE20121506A1
(es)
|
2006-07-14 |
2012-11-26 |
Amgen Inc |
Compuestos triazolopiridinas como inhibidores de c-met
|
US20080242694A1
(en)
*
|
2006-09-18 |
2008-10-02 |
D Sidocky Neil R |
Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
|
MX2009003793A
(es)
|
2006-10-09 |
2009-12-14 |
Takeda Pharmaceutical |
Inhibidores de cinasa.
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
US8916552B2
(en)
|
2006-10-12 |
2014-12-23 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
JP5518478B2
(ja)
|
2006-10-12 |
2014-06-11 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
WO2008044045A1
(en)
*
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
WO2008044029A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
GB0620259D0
(en)
|
2006-10-12 |
2006-11-22 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
KR20090082453A
(ko)
*
|
2006-11-01 |
2009-07-30 |
버텍스 파마슈티칼스 인코포레이티드 |
야누스 키나제의 억제제로서 유용한 트리사이클릭 헤테로아릴 화합물
|
US8148361B2
(en)
|
2006-11-10 |
2012-04-03 |
Bristol-Myers Squibb Company |
Kinase inhibitors
|
SI3034075T1
(sl)
*
|
2006-11-22 |
2018-12-31 |
Incyte Holdings Corporation |
Imidazotriazini in imidazopirimidini kot inhibitorji kinaze
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
CN101678022A
(zh)
|
2006-12-21 |
2010-03-24 |
弗特克斯药品有限公司 |
可用作蛋白激酶抑制剂的5-氰基-4-(吡咯并[2,3b]吡啶-3-基)嘧啶衍生物
|
PE20081581A1
(es)
*
|
2006-12-21 |
2008-11-12 |
Plexxikon Inc |
COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
WO2008080001A2
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
JP2010518014A
(ja)
*
|
2007-01-31 |
2010-05-27 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害剤として有用な2−アミノピリジン誘導体
|
GB0702259D0
(en)
*
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-azaindole derivatives
|
GB0702265D0
(en)
*
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-Azaindole derivatives
|
BRPI0809500A2
(pt)
*
|
2007-04-10 |
2014-09-23 |
Sgx Pharmaceuticals Inc |
Composto, e, métodos para modular a atividade de uma proteína quinase e para tratar uma doença
|
US8263585B2
(en)
*
|
2007-05-04 |
2012-09-11 |
Novartis Ag |
Organic compounds
|
WO2008144767A1
(en)
*
|
2007-05-21 |
2008-11-27 |
Sgx Pharmaceuticals, Inc. |
Heterocyclic kinase modulators
|
DE102007028515A1
(de)
*
|
2007-06-21 |
2008-12-24 |
Merck Patent Gmbh |
6-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
KR20100042276A
(ko)
*
|
2007-07-06 |
2010-04-23 |
파라테크 파마슈티컬스, 인크. |
치환 테트라사이클린 화합물의 합성방법
|
BRPI0814423B1
(pt)
|
2007-07-17 |
2022-04-19 |
Plexxikon, Inc |
Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos
|
EP2173722B1
(en)
*
|
2007-07-26 |
2012-08-29 |
Novartis AG |
Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
|
EP2211620B1
(en)
*
|
2007-10-25 |
2013-12-25 |
Merck Sharp & Dohme Corp. |
3-PYRAZIN SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AS JANUS KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES
|
US8598165B2
(en)
*
|
2007-11-26 |
2013-12-03 |
University Of Kansas |
Morpholines as selective inhibitors of cytochrome P450 2A13
|
US8268834B2
(en)
*
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
GB0806527D0
(en)
|
2008-04-11 |
2008-05-14 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
CN102131809A
(zh)
|
2008-07-23 |
2011-07-20 |
沃泰克斯药物股份有限公司 |
三环吡唑并吡啶激酶抑制剂
|
US8569337B2
(en)
|
2008-07-23 |
2013-10-29 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
EP2318407B1
(en)
|
2008-07-23 |
2013-01-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridine kinase inhibitors
|
JP5630867B2
(ja)
|
2008-08-05 |
2014-11-26 |
第一三共株式会社 |
イミダゾピリジン−2−オン誘導体
|
MX2011001370A
(es)
*
|
2008-08-05 |
2011-03-15 |
Abbott Lab |
Compuestos utiles como inhibidores de cinasas de proteina.
|
WO2010017350A1
(en)
|
2008-08-06 |
2010-02-11 |
Vertex Pharmaceuticals Incorporated |
Aminopyridine kinase inhibitors
|
ES2554375T3
(es)
|
2008-11-25 |
2015-12-18 |
University Of Rochester |
Inhibidores de las MLK y métodos de uso
|
JOP20190230A1
(ar)
*
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
FR2941948B1
(fr)
|
2009-02-12 |
2013-04-05 |
Nova Decision |
Derives d'azaindoles en tant qu'inhibiteur des proteines kinases abl et src
|
CR20170089A
(es)
|
2009-04-03 |
2017-07-17 |
Plexxikon Inc |
Composiciones del acido propano-1--sulfonico {3-[5-(4-cloro-fenil)-1h-pirrolo [2,3-b] piridina-3-carbonil] -2,4-difluoro-fenil}-amida y el uso de las mismas
|
WO2010129668A1
(en)
|
2009-05-06 |
2010-11-11 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridines
|
ES2604667T3
(es)
|
2009-06-17 |
2017-03-08 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de la replicación de virus de influenza
|
US8703808B2
(en)
|
2009-06-23 |
2014-04-22 |
Centre National De La Recherche Scientifique |
Use of derivatives of indoles for the treatment of cancer
|
EP2266562A1
(en)
*
|
2009-06-23 |
2010-12-29 |
Centre National de la Recherche Scientifique |
Use of derivatives of indoles for the treatment of cancer
|
US8329724B2
(en)
|
2009-08-03 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Process for the manufacture of pharmaceutically active compounds
|
GB0918924D0
(en)
*
|
2009-10-28 |
2009-12-16 |
Vantia Ltd |
Azaindole derivatives
|
WO2011057022A1
(en)
|
2009-11-06 |
2011-05-12 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
CU24167B1
(es)
|
2009-12-31 |
2016-03-31 |
Hutchison Medipharma Ltd |
Derivados de triazolopirazinas sustituidas como inhibidores del receptor c-met o hgf para tratar el cáncer
|
WO2011094288A1
(en)
|
2010-01-27 |
2011-08-04 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrazine kinase inhibitors
|
MX2012008643A
(es)
|
2010-01-27 |
2013-02-26 |
Vertex Pharma |
Inhibidores de cinasas de pirazolopiridinas.
|
CA2787315A1
(en)
|
2010-01-27 |
2011-08-04 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridine kinase inhibitors
|
JP2013518886A
(ja)
|
2010-02-03 |
2013-05-23 |
インフイニトイ プハルマセウトイカルス インコーポレイテッド |
脂肪酸アミドヒドロラーゼ阻害剤
|
CN103003274A
(zh)
*
|
2010-04-19 |
2013-03-27 |
Abbvie公司 |
激酶的吡咯并吡啶抑制剂
|
JP2013525490A
(ja)
*
|
2010-05-06 |
2013-06-20 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Faahのモジュレータとして有用なアザインドール誘導体
|
JP6086326B2
(ja)
|
2010-05-24 |
2017-03-01 |
ユニヴァーシティー オブ ロチェスター |
二環式ヘテロアリールキナーゼ阻害剤および使用方法
|
US8779150B2
(en)
*
|
2010-07-21 |
2014-07-15 |
Hoffmann-La Roche Inc. |
Processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1 H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide
|
KR20140014110A
(ko)
|
2010-12-16 |
2014-02-05 |
버텍스 파마슈티칼스 인코포레이티드 |
인플루엔자 바이러스 복제의 억제제
|
RS58455B1
(sr)
|
2011-02-07 |
2019-04-30 |
Plexxikon Inc |
Jedinjenja i postupci za modulaciju kinaze, i indikacije za njih
|
AR085279A1
(es)
|
2011-02-21 |
2013-09-18 |
Plexxikon Inc |
Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
|
US8791112B2
(en)
|
2011-03-30 |
2014-07-29 |
Arrien Pharmaceuticals Llc |
Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors
|
KR20140032430A
(ko)
|
2011-05-17 |
2014-03-14 |
플렉시콘, 인코퍼레이티드 |
키나제 조절 및 그에 대한 적응증
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
WO2013052355A1
(en)
|
2011-10-03 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
Azaindoles as janus kinase inhibitors
|
DE102011119127A1
(de)
*
|
2011-11-22 |
2013-05-23 |
Merck Patent Gmbh |
3-Cyanaryl-1H-pyrrolo[2.3-b]pyridin-Derivate
|
US9358235B2
(en)
|
2012-03-19 |
2016-06-07 |
Plexxikon Inc. |
Kinase modulation, and indications therefor
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
WO2014085795A1
(en)
|
2012-11-30 |
2014-06-05 |
University Of Rochester |
Mixed lineage kinase inhibitors for hiv/aids therapies
|
US9260426B2
(en)
*
|
2012-12-14 |
2016-02-16 |
Arrien Pharmaceuticals Llc |
Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
|
TWI634111B
(zh)
*
|
2013-03-15 |
2018-09-01 |
普雷辛肯公司 |
雜環化合物及其用途
|
US20140303121A1
(en)
|
2013-03-15 |
2014-10-09 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
US9206188B2
(en)
|
2013-04-18 |
2015-12-08 |
Arrien Pharmaceuticals Llc |
Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors
|
CN104119331B
(zh)
*
|
2013-04-26 |
2018-02-06 |
广东东阳光药业有限公司 |
烯基化合物及其使用方法和用途
|
GB2515785A
(en)
*
|
2013-07-03 |
2015-01-07 |
Redx Pharma Ltd |
Compounds
|
PL3068776T3
(pl)
|
2013-11-13 |
2019-10-31 |
Vertex Pharma |
Inhibitory replikacji wirusów grypy
|
SG10201804021TA
(en)
|
2013-11-13 |
2018-07-30 |
Vertex Pharma |
Methods of preparing inhibitors of influenza viruses replication
|
CA2973597A1
(en)
*
|
2015-01-23 |
2016-07-28 |
Confluence Life Sciences, Inc. |
Heterocyclic itk inhibitors for treating inflammation and cancer
|
KR101660863B1
(ko)
*
|
2015-04-03 |
2016-09-28 |
주식회사 녹십자 |
IKKε 및 TBK1 억제제로서의 7-아자인돌 또는 4,7-다이아자인돌 유도체 및 이를 포함하는 약학적 조성물
|
US10160755B2
(en)
*
|
2015-04-08 |
2018-12-25 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
JP6704416B2
(ja)
|
2015-05-13 |
2020-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
インフルエンザウイルスの複製の阻害剤を調製する方法
|
WO2016183120A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
EP3383875B1
(en)
*
|
2015-11-30 |
2022-02-09 |
Council Of Scientific & Industrial Research |
3-pyrimidinyl pyrrolo [2,3-b] pyridine as anticancer agents and the process for the preparation thereof
|
AU2016367147B2
(en)
|
2015-12-07 |
2021-04-08 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
US11331313B2
(en)
|
2017-05-22 |
2022-05-17 |
Whitehead Institute For Biomedical Research |
KCC2 expression enhancing compounds and uses thereof
|
WO2018226846A1
(en)
|
2017-06-07 |
2018-12-13 |
Plexxikon Inc. |
Compounds and methods for kinase modulation
|
CN107550905B
(zh)
*
|
2017-09-11 |
2020-07-17 |
浙江永宁药业股份有限公司 |
多取代吡咯并吡啶类化合物的药物用途及其制备方法
|
WO2019057660A1
(en)
*
|
2017-09-25 |
2019-03-28 |
Basf Se |
INDOLE AND AZAINDOLE COMPOUNDS HAVING 6-CHANNEL SUBSTITUTED ARYL AND HETEROARYL CYCLES AS AGROCHEMICAL FUNGICIDES
|
JP2020536917A
(ja)
|
2017-10-13 |
2020-12-17 |
プレキシコン インコーポレーテッドPlexxikon Inc. |
キナーゼを調節するための化合物の固体形態
|
WO2019169306A1
(en)
*
|
2018-03-01 |
2019-09-06 |
The Trustees Of Columbia University In The City Of New York |
Compounds, compositions, and methods for suppressing toxic endoplasmic reticulum stress
|
WO2020103896A1
(en)
*
|
2018-11-22 |
2020-05-28 |
Beigene, Ltd. |
Pyrrolo[2,3-b]pyridines as hpk1 inhibitor and uses thereof
|
JP2022527562A
(ja)
*
|
2019-04-09 |
2022-06-02 |
プレキシコン インコーポレーテッド |
Ep300またはcbpの調節のための縮合アジンおよびその適応
|
WO2022243648A1
(fr)
*
|
2021-05-21 |
2022-11-24 |
Centre National De La Recherche Scientifique (Cnrs) |
Nouveaux derives azaindole en tant qu'agents antiviraux
|
WO2023245329A1
(en)
*
|
2022-06-20 |
2023-12-28 |
Biofront Ltd |
Multi-kinase inhibitors, compositions thereof, and methods of using the same
|
WO2023245327A1
(en)
*
|
2022-06-20 |
2023-12-28 |
Biofront Ltd |
Multiple kinase degraders, compositions comprising the degrader, and methods of using the same
|